Trial
NCT00622466
Sorafenib and Paclitaxel in Treating Patients With Metastatic Breast Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Texas Southwestern Medical Center
Collaborators
—
Condition
Breast Cancer
Intervention
paclitaxel
Why stopped
Study sponsor requested that the study be permanently closed by letter.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-10-19